Clinical trials
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating trials in the United Kingdom
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
23 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2012 | 2 |
| 2014 | 1 |
| 2015 | 3 |
| 2016 | 1 |
| 2017 | 1 |
| 2019 | 2 |
| 2020 | 3 |
| 2022 | 2 |
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 5 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 11 |
| Recruiting | 6 |
| Terminated | 3 |
| Active, not recruiting | 1 |
| Enrolling by invitation | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| argenx | 4 |
| Baxalta now part of Shire | 2 |
| CSL Behring | 2 |
| Immunovant Sciences GmbH | 2 |
| Laboratoire français de Fractionnement et de Biotechnologies | 2 |
| Sanofi | 2 |
| Biogen | 1 |
| Dianthus Therapeutics | 1 |
| Janssen Research & Development, LLC | 1 |
| Novartis Pharmaceuticals | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Polyradiculoneuropathy, Chronic Inflammatory Demyelinating | 23 |
| Peripheral Nervous System Diseases | 3 |
| Autoimmune Diseases | 2 |
| Polyradiculoneuropathy | 2 |
| Rare Diseases | 2 |
| Amyloidosis, Familial | 1 |
| Autoimmune Diseases of the Nervous System | 1 |
| Demyelinating Diseases | 1 |
| Guillain-Barre Syndrome | 1 |
| Immune System Diseases | 1 |
Trials
Showing 1 to 23 of 23. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.